Trademark: 98148347
Word
BIOCON BIOLOGICS TRANSFORMING HEALTHCARE. TRANSFORMING LIVES.
Status
Pending
Status Code
681
Status Date
Monday, June 10, 2024
Serial Number
98148347
Mark Type
3
Filing Date
Thursday, August 24, 2023
Published for Opposition
Tuesday, July 16, 2024

Trademark Owner History

Classifications
5 Pharmaceuticals and medical preparations used in the field of diabetology, oncology, nephrology, endocrinology, immunology for treatment of diabetes and cancer; pharmaceutical and medical preparations for treatment of metabolic disorders; pharmaceutical preparations used in treatment of diabetes, cancer, renal disorder, heart diseases, autoimmune diseases, bacterial and viral infections
16 Paper and paper articles, namely, cardboard and cardboard articles in the nature of cardboard boxes; printed matter in the nature of publications, namely, journals, books, articles, brochures and newsletters in the field of pharmacy and medicine; printed newspapers; printed periodicals in the field of pharmacy and medicine; printed books in the field of pharmacy and medicine; office requisites, namely, rubber stamp, envelopes, document files and printed diaries; bags of paper for packaging; printed name cards; printed leaflets in the field of pharmacy and medicine; printed instructional and teaching materials in the field of pharmacy and medicine
1 Chemicals for use in industry, science and photography, chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins, unprocessed plastics; fire extinguishing and fire prevention compositions; tempering and soldering preparations; substances for tanning animal skins and hides, namely, tanning agents for use in the manufacture of leather; adhesives for use in industry; oil cement putty; paste fillers for automotive body repairer; compost, manures, fertilizers; biological preparations for use in industry and science
10 Surgical and medical apparatus, devices and instruments, namely, injectors for medical purposes, needles for medical purposes, insulin injector pens sold empty; injection needles; hypodermic injection needles; insulin injector pens sold empty; injection devices for pharmaceuticals; injection instruments without needles; automatic medical apparatus for dosing humans by injection
42 Pharmaceutical research and development; medical and scientific research services in the field of cancer treatment and diagnosis, cardiology, nephrology, endocrinology; chemical, biochemical, biological and bacteriological research and analysis
The mark consists of the wording "BIOCON BIOLOGICS" displayed above the wording "TRANSFORMING HEALTHCARE. TRANSFORMING LIVES." A design of two bands comprised of shorter bands attached to circles is displayed to the left of the wording.
Color is not claimed as a feature of the mark.
"BIOLOGICS"

Trademark Events
Aug 28, 2023
New Application Entered
Sep 24, 2023
New Application Office Supplied Data Entered
Sep 25, 2023
Assigned To Examiner
Sep 26, 2023
Notice Of Design Search Code E-Mailed
Sep 29, 2023
Non-Final Action Written
Sep 29, 2023
Non-Final Action E-Mailed
Sep 29, 2023
Notification Of Non-Final Action E-Mailed
Oct 10, 2023
Teas Response To Office Action Received
Oct 10, 2023
Correspondence Received In Law Office
Oct 10, 2023
Teas/Email Correspondence Entered
Nov 27, 2023
Non-Final Action Written
Nov 27, 2023
Non-Final Action E-Mailed
Nov 27, 2023
Notification Of Non-Final Action E-Mailed
Feb 23, 2024
Non-Final Action Written
Feb 23, 2024
Non-Final Action E-Mailed
May 15, 2024
Correspondence Received In Law Office
May 15, 2024
Teas/Email Correspondence Entered
May 15, 2024
Teas Response To Office Action Received
Jun 7, 2024
Examiners Amendment -Written
Jun 7, 2024
Examiner's Amendment Entered
Jun 7, 2024
Notification Of Examiners Amendment E-Mailed
Jun 7, 2024
Approved For Pub - Principal Register
Jun 7, 2024
Examiners Amendment E-Mailed
Jun 26, 2024
Notification Of Notice Of Publication E-Mailed
Feb 23, 2024
Notification Of Non-Final Action E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24